A guide for life sciences entrepreneurs


Chad Shear

A guide for life sciences entrepreneurs

Flamingo Images / Shutterstock.com

Small companies face the same long product cycles and upfront costs as the big players but have different IP challenges, explains Chad Shear of Fish & Richardson.

The strength of a company’s IP is a central factor in determining its value, and perhaps nowhere is this more evident than in the life sciences industry. Because of the huge upfront expenditures required to develop products in the pharmaceutical, biotechnology, and other life sciences industries, a strong IP portfolio can be the difference between success and failure.

Life sciences entrepreneurs often face different IP challenges from those in other industries due to long product life cycles and expensive research and development (R&D), among other concerns.   

Long product life cycles

Fish & Richardson, entrepreneurs, IP portfolio, pharmaceuticals, biotechnology, life sciences, R&D, patent protection, investment, FDA, infringement

More on this story

LSIPR 50 2018: The entrepreneurial bug